癌症相关成纤维细胞在转移前生态位形成中的作用
作者单位:

1.河北北方学院基础医学院/微循环研究所;2.河北北方学院;3.河北北方学院附属第一医院

基金项目:

河北省自然科学基金资助项目(H2021405030);


Role of Cancer-Associated Fibroblasts in the Formation of the Pre-Metastatic Niche
Author:
Affiliation:

1. Basic Medical College Institute of Microcirculation,Hebei North University

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [53]
  • | | | |
  • 文章评论
    摘要:

    随着全球癌症发病率的不断上升,肿瘤转移已成为导致大多数癌症患者死亡的主要原因。转移前生态位的形成为肿瘤细胞的定植和转移提供了理想的微环境,极大地促进了肿瘤的扩散。在这一过程中,癌症相关成纤维细胞(CAFs)因其在肿瘤进展中的多重作用而备受关注。CAFs通过重塑细胞外基质、诱导上皮间质转化、刺激新生血管生成以及调控肿瘤免疫微环境,推动了转移前生态位的建立和肿瘤细胞的侵袭性行为。这些作用不仅加速了肿瘤的转移进程,还为肿瘤的免疫逃逸创造了条件。本文综述了CAFs在肿瘤转移中的核心机制和功能,探讨了其在癌症研究和治疗中的潜在应用,为抗肿瘤转移策略的开发提供了新的视角与方向。

    Abstract:

    As the global incidence of cancer continues to rise, tumor metastasis has emerged as the leading cause of death among cancer patients. The formation of the pre-metastatic niche creates a favorable microenvironment for tumor cell colonization and metastasis, significantly driving the spread of cancer. In this context, cancer-associated fibroblasts (CAFs) have garnered significant attention for their multifaceted roles in tumor progression. CAFs contribute to the establishment of the pre-metastatic niche and enhance the invasive behavior of tumor cells by remodeling the extracellular matrix, inducing epithelial-mesenchymal transition, stimulating angiogenesis, and modulating the tumor immune microenvironment. These actions not only accelerate the metastatic process but also facilitate immune evasion by the tumor. This review delves into the pivotal mechanisms and functions of CAFs in tumor metastasis, exploring their potential applications in cancer research and therapy, and offering new perspectives for the development of anti-metastatic strategies.

    参考文献
    [1] CHENG J N, YUAN Y X, ZHU B, et al. Myeloid-Derived Suppressor Cells: A Multifaceted Accomplice in Tumor Progression [J]. Front Cell Dev Biol, 2021, 9: 740827.
    [2] JANG I, BENINGO K A. Integrins, CAFs and Mechanical Forces in the Progression of Cancer [J]. Cancers (Basel), 2019, 11(5).
    [3] RIZZOLIO S, GIORDANO S, CORSO S. The importance of being CAFs (in cancer resistance to targeted therapies) [J]. J Exp Clin Cancer Res, 2022, 41(1): 319.
    [4] TSOUMAKIDOU M. The advent of immune stimulating CAFs in cancer [J]. Nat Rev Cancer, 2023, 23(4): 258-69.
    [5] PAPAIT A, ROMOLI J, STEFANI F R, et al. Fight the Cancer, Hit the CAF! [J]. Cancers (Basel), 2022, 14(15).
    [6] WRIGHT K, LY T, KRIET M, et al. Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers [J]. Cancers (Basel), 2023, 15(6).
    [7] CANNONE S, GRECO M R, CARVALHO T M A, et al. Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition [J]. Cancers (Basel), 2022, 14(15).
    [8] LIU X, LI J, YANG X, et al. Carcinoma-associated fibroblast-derived lysyl oxidase-rich extracellular vesicles mediate collagen crosslinking and promote epithelial-mesenchymal transition via p-FAK/p-paxillin/YAP signaling [J]. Int J Oral Sci, 2023, 15(1): 32.
    [9] WINKLER J, ABISOYE-OGUNNIYAN A, METCALF K J, et al. Concepts of extracellular matrix remodelling in tumour progression and metastasis [J]. Nat Commun, 2020, 11(1): 5120.
    [10] YU C-C, KIM D K, KIM E K, et al. Cytoskeletal alteration modulates cancer cell invasion through RhoA-YAP signaling in stromal fibroblasts [J]. Plos One, 2019, 14(3).
    [11] LIU T, ZHOU L, YANG K, et al. The β-catenin/YAP signaling axis is a key regulator of melanoma-associated fibroblasts [J]. Signal Transduction and Targeted Therapy, 2019, 4(1).
    [12] FATTET L, JUNG H-Y, MATSUMOTO M W, et al. Matrix Rigidity Controls Epithelial-Mesenchymal Plasticity and Tumor Metastasis via a Mechanoresponsive EPHA2/LYN Complex [J]. Developmental Cell, 2020, 54(3): 302-16.e7.
    [13] TAKATSU F, SUZAWA K, TOMIDA S, et al. Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer [J]. J Mol Med (Berl), 2023, 101(12): 1603-14.
    [14] GHOFRANI-SHAHPAR M, PAKRAVAN K, RAZMARA E, et al. Cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production [J]. BMC Cancer, 2024, 24(1): 400.
    [15] JIANG B, XIAO S, ZHANG S, et al. The miR-1290/OGN axis in ovarian cancer-associated fibroblasts modulates cancer cell proliferation and invasion [J]. J Ovarian Res, 2024, 17(1): 52.
    [16] ZHANG Y, SUN S, QI Y, et al. Characterization of tumour microenvironment reprogramming reveals invasion in epithelial ovarian carcinoma [J]. J Ovarian Res, 2023, 16(1): 200.
    [17] KUMAR D, NEW J, VISHWAKARMA V, et al. Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression [J]. Cancer Res, 2018, 78(14): 3769-82.
    [18] AWAJI M, FUTAKUCHI M, HEAVICAN T, et al. Cancer-Associated Fibroblasts Enhance Survival and Progression of the Aggressive Pancreatic Tumor Via FGF-2 and CXCL8 [J]. Cancer Microenviron, 2019, 12(1): 37-46.
    [19] BORDIGNON P, BOTTONI G, XU X, et al. Dualism of FGF and TGF-beta Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant [J]. Cell Rep, 2019, 28(9): 2358-72 e6.
    [20] CHEN J, HUANG Q, LI Y Q, et al. Comparative single-cell analysis reveals heterogeneous immune landscapes in adenocarcinoma of the esophagogastric junction and gastric adenocarcinoma [J]. Cell Death Dis, 2024, 15(1): 15.
    [21] SOONGSATHITANON J, JAMJUNTRA P, SUMRANSUB N, et al. Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer [J]. J Immunol Res, 2021, 2021: 8840066.
    [22] MORI Y, OKIMOTO Y, SAKAI H, et al. Targeting PDGF signaling of cancer-associated fibroblasts blocks feedback activation of HIF-1alpha and tumor progression of clear cell ovarian cancer [J]. Cell Rep Med, 2024, 5(5): 101532.
    [23] REN X, LI L, WU J, et al. PDGF-BB regulates the transformation of fibroblasts into cancer-associated fibroblasts via the lncRNA LURAP1L-AS1/LURAP1L/IKK/IkappaB/NF-kappaB signaling pathway [J]. Oncol Lett, 2021, 22(1): 537.
    [24] YOU D, WANG Y, XU J, et al. MiR-3529-3p from PDGF-BB-induced cancer-associated fibroblast-derived exosomes promotes the malignancy of oral squamous cell carcinoma [J]. Discov Oncol, 2023, 14(1): 166.
    [25] CADAMURO M, BRIVIO S, MERTENS J, et al. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma [J]. J Hepatol, 2019, 70(4): 700-9.
    [26] YAN J, XIAO G, YANG C, et al. Cancer-Associated Fibroblasts Promote Lymphatic Metastasis in Cholangiocarcinoma via the PDGF-BB/PDGFR-beta Mediated Paracrine Signaling Network [J]. Aging Dis, 2024, 15(1): 369-89.
    [27] ZHOU J, SCHWENK-ZIEGER S, KRANZ G, et al. Isolation and characterization of head and neck cancer-derived peritumoral and cancer-associated fibroblasts [J]. Front Oncol, 2022, 12: 984138.
    [28] GUO X, CHEN M, CAO L, et al. Cancer-Associated Fibroblasts Promote Migration and Invasion of Non-Small Cell Lung Cancer Cells via miR-101-3p Mediated VEGFA Secretion and AKT/eNOS Pathway [J]. Front Cell Dev Biol, 2021, 9: 764151.
    [29] WAN X, GUAN S, HOU Y, et al. FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts [J]. Theranostics, 2021, 11(10): 4975-91.
    [30] YANG Y, MA Y, YAN S, et al. CAF promotes chemoresistance through NRP2 in gastric cancer [J]. Gastric Cancer, 2022, 25(3): 503-14.
    [31] LIU Y, QU H C, HUANG Y. Renal clear cell carcinoma-derived CXCL5 drives tumor-associated fibroblast formation and facilitates cancer progression [J]. Pathol Res Pract, 2023, 244: 154319.
    [32] OSTRAND-ROSENBERG S, LAMB T J, PAWELEC G. Here, There, and Everywhere: Myeloid-Derived Suppressor Cells in Immunology [J]. J Immunol, 2023, 210(9): 1183-97.
    [33] LIANG T, TAO T, WU K, et al. Cancer-Associated Fibroblast-Induced Remodeling of Tumor Microenvironment in Recurrent Bladder Cancer [J]. Adv Sci (Weinh), 2023, 10(31): e2303230.
    [34] SUN R, LUO H, SU J, et al. Olaparib Suppresses MDSC Recruitment via SDF1alpha/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice [J]. Mol Ther, 2021, 29(1): 60-74.
    [35] MONTERAN L, ERSHAID N, DORON H, et al. Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer [J]. Nat Commun, 2022, 13(1): 5797.
    [36] JIN H, KIM H J. NK Cells Lose Their Cytotoxicity Function against Cancer Stem Cell-Rich Radiotherapy-Resistant Breast Cancer Cell Populations [J]. Int J Mol Sci, 2021, 22(17).
    [37] WANG L, CAO Y, GUO W, et al. High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD) [J]. J Cancer Res Clin Oncol, 2023, 149(1): 15-24.
    [38] VAN DEN EYNDE A, GEHRCKEN L, VERHEZEN T, et al. IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts [J]. J Hematol Oncol, 2024, 17(1): 8.
    [39] LEE Y E, GO G Y, KOH E Y, et al. Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6 [J]. J Immunother Cancer, 2023, 11(2).
    [40] YAO L, HOU J, WU X, et al. Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation [J]. Redox Biol, 2023, 67: 102923.
    [41] PENG Z, YE M, DING H, et al. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer [J]. J Transl Med, 2022, 20(1): 302.
    [42] LUAN J, LIU Y, CAO M, et al. The pathogenic response of cytotoxic T?lymphocytes, a common therapeutic target for cancer, has a direct impact on treatment outcomes (Review) [J]. Oncol Rep, 2024, 52(1).
    [43] AGORKU D J, BOSIO A, ALVES F, et al. Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling [J]. Cancer Lett, 2024, 595: 216985.
    [44] GORCHS L, KAIPE H. Interactions between Cancer-Associated Fibroblasts and T Cells in the Pancreatic Tumor Microenvironment and the Role of Chemokines [J]. Cancers (Basel), 2021, 13(12).
    [45] LOU M, IWATSUKI M, WU X, et al. Cancer-Associated Fibroblast-Derived IL-8 Upregulates PD-L1 Expression in Gastric Cancer Through the NF-kappaB Pathway [J]. Ann Surg Oncol, 2024, 31(5): 2983-95.
    [46] LI X, ZHAI J, SHEN Y, et al. Tumor-derived IL-8 facilitates lymph node metastasis of gastric cancer via PD-1 up-regulation in CD8(+) T cells [J]. Cancer Immunol Immunother, 2022, 71(12): 3057-70.
    [47] BLINOVA V G, ZHDANOV D D. Many Faces of Regulatory T Cells: Heterogeneity or Plasticity? [J]. Cells, 2024, 13(11).
    [48] VARVERI A, PAPADOPOULOU M, PAPADOVASILAKIS Z, et al. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development [J]. Nat Commun, 2024, 15(1): 4988.
    [49] SUN R Z H, GAO DS, NI A, LI H, CHEN L, LU X, CHEN K, LU B. Amphiregulin couples IL1RL1+regulatory T cells and cancer-associated fibroblasts to impede antitumor immunit [J]. Sci Adv, Epub 2023 Aug 23., 9(34):eadd7399.
    [50] DONG G, CHEN P, XU Y, et al. Cancer-associated fibroblasts: Key criminals of tumor pre-metastatic niche [J]. Cancer Lett, 2023, 566: 216234.
    [51] DHUNGEL N, DRAGOI A-M. Exploring the multifaceted role of direct interaction between cancer cells and fibroblasts in cancer progression [J]. Frontiers in Molecular Biosciences, 2024, 11.
    [52] GUO T, XU J. Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy [J]. Cancer and Metastasis Reviews, 2024, 43(3): 1095-116.
    [53] GENG X, CHEN H, ZHAO L, et al. Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer [J]. Front Cell Dev Biol, 2021, 9: 655152.
    相似文献
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文
分享
文章指标
  • 点击次数:112
  • 下载次数: 0
  • HTML阅读次数: 0
  • 引用次数: 0
历史
  • 收稿日期:2024-09-05
  • 最后修改日期:2024-10-19
  • 录用日期:2025-01-08
防诈骗提示!请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭